Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laurent Guy

Showing results (41-50 of 85) with videos related to

Pageof 9
Sort By:
BJU International|March 22, 2021
Artificial intelligence to improve cytology performances in bladder carcinoma detection: results of the VisioCyt testThierry Lebret, Geraldine Pignot, Marc Colombel, et al.
In Vivo (Athens, Greece)|May 21, 2009
Methylation analysis of BRCA1, RASSF1, GSTP1 and EPHB2 promoters in prostate biopsies according to different degrees of malignancyNadège Rabiau, Mohamed Oury Thiam, Samir Satih, et al.
Expert Opinion on Therapeutic Targets|July 24, 2013
Oxysterol receptors and their therapeutic applications in cancer conditionsHugues De Boussac, Anthony Alioui, Emilie Viennois, et al.
In Vivo (Athens, Greece)|May 6, 2009
Immunohistochemical staining of mucin 1 in prostate tissuesNadege Rabiau, Pierre Dechelotte, Laurent Guy, et al.
Nutrition and Cancer|June 28, 2008
Orally administered isoflavones are present as glucuronides in the human prostateLaurent Guy, Nicolas Védrine, Mireia Urpi-Sarda, et al.
The French Journal of Urology|February 23, 2024
Surgical management for penile fracture: A retrospective, observational, multicenter studyAngèle Reichenbach, Pierre Gayrel, Nicolas Morel Journel, et al.
Epigenomics|October 22, 2014
Epigenetic modifications in prostate cancerMarjolaine Ngollo, Aslihan Dagdemir, Seher Karsli-Ceppioglu, et al.
Anticancer Research|May 16, 2009
Genetic polymorphisms in CYP1A1, CYP1B1, COMT, GSTP1 and NAT2 genes and association with bladder cancer risk in a French cohortLuc Fontana, Laetitia Delort, Laurie Joumard, et al.
Omics : a Journal of Integrative Biology|June 14, 2013
Gene panel model predictive of outcome in patients with prostate cancerNadège Rabiau, Yann Dantal, Laurent Guy, et al.
BMC Cancer|April 14, 2017
Global analysis of H3K27me3 as an epigenetic marker in prostate cancer progressionMarjolaine Ngollo, Andre Lebert, Marine Daures, et al.
Pageof 9

Showing results (41-50 of 85) with videos related to

Sort By:
Pageof 9
BJU International|March 22, 2021
Artificial intelligence to improve cytology performances in bladder carcinoma detection: results of the VisioCyt testThierry Lebret, Geraldine Pignot, Marc Colombel, et al.
In Vivo (Athens, Greece)|May 21, 2009
Methylation analysis of BRCA1, RASSF1, GSTP1 and EPHB2 promoters in prostate biopsies according to different degrees of malignancyNadège Rabiau, Mohamed Oury Thiam, Samir Satih, et al.
Expert Opinion on Therapeutic Targets|July 24, 2013
Oxysterol receptors and their therapeutic applications in cancer conditionsHugues De Boussac, Anthony Alioui, Emilie Viennois, et al.
In Vivo (Athens, Greece)|May 6, 2009
Immunohistochemical staining of mucin 1 in prostate tissuesNadege Rabiau, Pierre Dechelotte, Laurent Guy, et al.
Nutrition and Cancer|June 28, 2008
Orally administered isoflavones are present as glucuronides in the human prostateLaurent Guy, Nicolas Védrine, Mireia Urpi-Sarda, et al.
The French Journal of Urology|February 23, 2024
Surgical management for penile fracture: A retrospective, observational, multicenter studyAngèle Reichenbach, Pierre Gayrel, Nicolas Morel Journel, et al.
Epigenomics|October 22, 2014
Epigenetic modifications in prostate cancerMarjolaine Ngollo, Aslihan Dagdemir, Seher Karsli-Ceppioglu, et al.
Anticancer Research|May 16, 2009
Genetic polymorphisms in CYP1A1, CYP1B1, COMT, GSTP1 and NAT2 genes and association with bladder cancer risk in a French cohortLuc Fontana, Laetitia Delort, Laurie Joumard, et al.
Omics : a Journal of Integrative Biology|June 14, 2013
Gene panel model predictive of outcome in patients with prostate cancerNadège Rabiau, Yann Dantal, Laurent Guy, et al.
BMC Cancer|April 14, 2017
Global analysis of H3K27me3 as an epigenetic marker in prostate cancer progressionMarjolaine Ngollo, Andre Lebert, Marine Daures, et al.
Pageof 9